Some Stem Cell Experts Want Out of Documentary After Funding Source Revealed
By Erin Allday,
San Francisco Chronicle
| 06. 15. 2019
A new documentary about stem cell therapy is being questioned by some of those who appear in it — prominent cellular scientists who say they weren’t aware of who was backing the project when they agreed to participate.
The 10-part series is set to launch online Monday. The filmmakers said they may delay the premiere because some people interviewed for the project no longer want to be involved, after learning that the movie was funded in part by for-profit stem cell providers who are under federal investigation. Some scientists said they fear the documentary may promote what they consider junk science.
A five-minute trailer for “The Healthcare Revolution” is online at the website www.healthcarerev.org, where a surprisingly deep lineup of “expert sources” in stem cells is listed along with the institutions they represent.
Among the scientists named is Dr. Maria Millan, head of the California Institute for Regenerative Medicine, the state’s stem cell funding agency. Also named are three consumer stem cell providers who have been sued by the U.S. Food and Drug Administration to stop their operations; one...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...